Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (US FDA) to manufacture and market benazepril hydrochloride tablets, 10, 20 and 40 mg. Benazepril HCl tablets are the generic equivalent of Novartis Pharmaceuticals' lotensin tablets, which are indicated for the treatment of hypertension.
According to the company, it is their 69th ANDA approval from the US FDA. Since April 2008, the company has also received the final approval for its anti-infective product penicillin V potassium tablets USP 250 mg and 500 mg and tentative approval for its anti-AIDS product emtricitabine capsules 200mg from the US FDA.